Descripción del proyecto
Una alternativa al cuero capta el interés de las marcas de calzado
La industria del cuero es un mercado de 100 000 millones USD que implica procesos crueles e ineficaces, incluido el sacrificio de miles de millones de animales. Aunque los fabricantes de cuero tienen un gran impacto en el medio ambiente, no ha existido ninguna alternativa destacable a la piel natural. BacLEATHER ofrece la alternativa de un biomaterial parecido al cuero. Este material se produce mediante fermentación bacteriana a través de una tecnología patentada que imita las características del cuero de manera eficaz. Destacadas empresas de calzado ya han conseguido producir el material en series cortas y se han establecido colaboraciones con las principales marcas de calzado. BacLEATHER espera entrar en el mercado del cuero, que crece rápidamente, y lograr un flujo de caja acumulado de 16,75 millones EUR en cinco años.
Objetivo
The global leather business is still mainly dependent on raising and slaughtering of billions of animals. This, in the XXI century is not only an inefficient and cruel process but also, it creates a huge environmental impact, which could be avoidable. Unfortunately, brands and shoes manufacturers have no ecological alternative to natural leather that can reproduce successfully its key characteristics from the consumer point of view.
Existing alternatives in the market, mainly PVC bases synthetic leather, do not only show poorer performance from client perspective but also they still create a huge environment impact. Potential clients across the world (Inditex and Louis Vuitton in Europe; Puma, Adidas and Nike in USA) do confirm there is a clear trend towards the development of safer, toxic-free, sustainable, environmental-friendly and more ethical footwear and leather goods. Furthermore they confirm the need of new materials to increase their productivity and profitability while reducing the use of hazardous chemicals in tanning practices.
Considering the size of the leather market (estimated around 100bn$ by 2019, CAGR 3,4%) and these comments from clients, we see very high potential in upscaling to industrial level the results we obtained so far with BacLEATHER, a leather-like biomaterial. This material is produced by bacterial fermentation through a proprietary technology and mimics leather characteristics. Patent Shoes, S.L. has already been able to produce the material in short series and we have already established a collaboration with TEMPE, from GRUPO INDITEX (one of the most important brand footwear companies, owner of ZARA brand, among others) in order to prepare the material for its market-fit within the footwear vertical. We see in the BacLEATHER project a clear investment opportunity, in which we seek entering the fast growing leather-like market and achieve a five-year cumulative cash flow of €16,75 M€, meaning a 5-years ROI of 610%.
Ámbito científico
Programa(s)
Convocatoria de propuestas
Consulte otros proyectos de esta convocatoriaConvocatoria de subcontratación
H2020-SMEInst-2018-2020-1
Régimen de financiación
SME-1 - SME instrument phase 1Coordinador
28010 MADRID
España
Organización definida por ella misma como pequeña y mediana empresa (pyme) en el momento de la firma del acuerdo de subvención.